CCX-559

N/A

Report date: 2022/06/13 14:27:23

NME

Base Information

Drug NameCCX-559

Drug Alias NameCCX-559

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProgrammed death-ligand 1 blockers

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesChemocentryx Inc

China Registration ClassN/A

Active CompaniesChemocentryx

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsNeoplasms

ATC CodeN/A